Apimeds pharmaceuticals says “i love my ducks” with new ai² futures lab™ program collaboration with the university of oregon's lundquist college of business

Matawan, n.j. & eugene, ore.--(business wire)--apimeds pharmaceuticals us, inc. (nyse: apus) (“apimeds”) today announced the expansion of the apimeds ai² futures lab program through a new collaboration with the university of oregon's lundquist college of business, starting with the winter 2026 quarter. the initiative connects student teams with real-world biopharma business development projects, reinforcing apimeds' commitment to fostering innovation, leadership, and discovery across the health.
APUS Ratings Summary
APUS Quant Ranking